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Objectives: Endovascular aneurysm repair (EVAR) is commonly per-
formed by interventional radiologists, cardiologists, general surgeons,
cardiothoracic surgeons, and vascular surgeons, with each specialty having
differences in residency structure, operative experience, and subspecialty
training. The aim of this study was to evaluate the effect of surgeon specialty
on outcomes after EVAR.
Methods: Patients who underwent EVAR were identiﬁed from the
2007-2009 Nationwide Inpatient Sample (NIS). Physician identiﬁers in
the NIS were used to determine surgical specialty and operative experience.
Multivariate analysis adjusted for mortality risk was used to compare differ-
ences in demographics, complications, outcomes, and hospital covariates.Table I. Patient characteristics by specialty
Variable Interventional radiologist Interventional cardio
Demographics
Total cases, No. (%) 373 (7.2) 141 (2.7)
Age, years 73.6 6 10.4 73.4 6 9.1
Female gender, % 19.8 17.7
Elective, % 79.9 82.9
DRG mortality risk 1.8 6 0.9 1.9 6 0.9
DRG severity of illness 1.9 6 0.9 1.9 6 0.8
Complications, %
Bleeding 4.6 2.8
Stroke 0.3 0.0
Cardiac 1.6 1.4
Respiratory 0.0 0.0
Vascular 0.3 0.7
SSI 0.3 0.0
Other 1.3 0.0
Outcomes
Length of stay, days 4.0 6 4.9 3.2 6 3.5
Costs $38,667c $33,599
Mortality, % 1.3 0.7
Hospital covariates, %
Urban location 93.4 96.9
Teaching hospital 38.0c 40.6
DRG, Diagnosis-Related Group; SSI, surgical site infection.
aP < .01.
bP < .05.
cP < .001.
Table II. Mortality risk-adjusted multivariate analysis of practitioner specialty an
Variable
Interventional radiologist Interventional cardiologist
OR CI P OR CI P OR
Bleeding 1.32 0.79-2.20 NS 0.81 0.29-2.21 NS 0.5
Stroke 1.22 0.16-9.55 NS N/A
Cardiac 0.78 0.34-1.80 NS 0.69 0.17-2.83 NS
Respiratory N/A N/A
Vascular 0.28 0.038-2.00 NS 0.73 0.10-5.34 NS
SSI 0.76 0.10-5.76 NS N/A
Other 1.92 0.74-4.95 NS N/A
Death 0.54 0.22-1.33 NS 0.28 0.040-2.04 NS 3.1
CI, Conﬁdence interval; N/A, not applicable; NS, not signiﬁcant; OR, odds rat
572Results: A total of 5147 EVARs were identiﬁed within the NIS, of
which 88.3% were completed by vascular surgeons. There were no signiﬁcant
differences in demographics between the specialties (Table I). Cardiothoracic
surgeons were more likely to have a postoperative stroke (3.1% vs 0.2%; odds
ratio [OR], 14.6; 95% conﬁdence interval (CI), 1.8-117.8; P< .05; Table II)
and cardiac complications (9.4% vs 2.0%; OR, 5.0; 95%CI, 1.5-16.6; P< .01)
compared with other specialties. Vascular surgeons were somewhat more
likely to have postoperative respiratory complications (0.7% vs 0.0%; P <
.05). Overall costs were lowest for vascular surgeons ($32,094), and highest
for cardiothoracic surgeons ($41,663; P < .05). Postoperative mortality was
highest for general surgeons (7.4% vs 2.5%; OR, 3.2; 95% CI, 1.1-8.9; P <
.05). Only vascular surgeons completed >10 EVARs per year (Table III).
Conclusions: Physician specialty and operative experience affect pa-
tient outcome after EVAR. Low-volume surgeons have a higher rate of
complications, cost, and mortality, but this was not the case for interven-
tional cardiologists or radiologists. These ﬁndings may affect patient referral
patterns and hospital privileges for providers.logist General surgeon Cardiothoracic surgeon Vascular surgeon
54 (1.0) 32 (0.6) 4547 (88.3)
73.9 6 11.4 67.1 6 11.7 73.7 6 8.7
22.2 18.8 18.6
74.1 75.0 82.7
2.9 6 1.2a 1.9 6 1.1 1.8 6 0.9
2.9 6 0.9a 1.9 6 1.0 1.9 6 0.8
1.9 3.1 3.5
0.0 3.1a 0.2
0.0 9.4a 2.0
0.0 0.0 0.7b
0.0 3.1 1.0
0.0 0.0 0.4
0.0 0.0 0.7
4.5 6 10.6 5.4 6 7.0 3.7 6 7.1
$33,274 $41,663b $32,094c
7.4b 6.3 2.5
100 100 95.1
71.4 73.3 58.4c
d outcomes after endovascular aneurysm repair (EVAR)
General surgeon Cardiothoracic surgeon Vascular surgeon
CI P OR CI P OR CI P
2 0.072-3.79 NS 0.89 0.12-6.56 NS Reference
N/A 14.64 1.82-117.83 <.05 Reference
N/A 4.95 1.48-16.55 <.01 Reference
N/A N/A Reference
N/A 3.30 0.44-24.72 NS Reference
N/A N/A Reference
N/A N/A Reference
7 1.13-8.92 <.05 2.64 0.62-11.18 NS Reference
io; SSI, surgical site infection.
Table III. Effect of volume on endovascular aneurysm repair (EVAR) outcomes by physician specialty
Variable
Interventional radiologist Interventional cardiologist General surgeon Cardiothoracic surgeon Vascular surgeon
Low volume Low volume Low volume Low volume Low volume High volume
Bleeding, % 4.6 2.8 1.9 3.1 3.7 2.9
Stroke, % 0.3 0.0 0.0 3.1 0.3 0.1
Cardiac, % 1.6 1.4 0.0 9.4 2.0 2.1
Respiratory, % 0.0 0.0 0.0 0.0 0.6 0.1
Vascular, % 0.3 0.7 0.0 3.1 1.0 0.7
SSI, % 0.3 0.0 0.0 0.0 0.4 0.1
Other, % 1.3 0.0 0.0 0.0 0.8 0.5
Length of stay, days 4.0 6 4.9 3.2 6 3.5 4.5 6 10.6 5.4 6 7.0 3.8 6 7.6 3.5 6 2.0
Costs $32,858 $33,599 $33,274 $25,801 $32,130 $31,950
Mortality, % 1.3 0.7 7.4 6.3 2.4 2.7
SSI, Surgical site infection.
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Aneurysms Does Not Independently Reduce Long-Term
Mortality Compared With Open Repair
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MPH, Elias Arous, MD, Louis M. Messina, MD. University of
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Objectives: Endovascular repair (EVAR) of ruptured abdominal
aortic aneurysms (RAAAs) reduces in-hospital mortality compared with
open repair (OR) but it is unknown whether EVAR reduces long-term mor-
tality. We hypothesized that EVAR of RAAA would independently reduce
long-term mortality compared with OR.
Methods: The Vascular Quality Initiative (VQI) database (2003-
2013) was used to determine Kaplan-Meier 1-year and 5-year mortality after
EVAR and OR of RAAA. Multivariate analysis was performed to identify pa-
tient and operative characteristics associated with mortality at 1 and 5 years
after RAAA repair.
Results: Among 590 patients who underwent EVAR and 692 patients
who underwent OR of RAAA, the lower mortality seen in-hospital after
EVAR (EVAR: 23% vs OR: 35%; P < .001) persisted at 1 year (EVAR: 34%
vs OR: 42%; P ¼ .001) and 5 years (EVAR: 50% vs OR: 58%; P ¼ .003;
Fig) after repair. After adjusting for patient and operative characteristics,
EVAR did not independently reduce mortality at 1 year (hazard ratio [HR],
0.88 [95% conﬁdence interval, 0.7-1.1]) or 5 years (HR, 0.95 [.77-1.2])
compared with OR. Women (HR, 1.3 [1.04-1.6]), age (HR, 1.06 [1.05-
1.08] per 5 years), homeoxygenuse (HR, 1.9 [1.3-2.7]), dialysis-dependence
(HR, 3.9 [1.8-8.6]), cardiac ejection fraction<50% (HR, 1.5 [1.03-2.1]), as
well as preoperative systolic blood pressure<90mmHg (HR, 1.4 [1.1-1.8]),
loss of consciousness (HR, 1.7 [1.3-2.2]), and cardiac arrest (HR, 3.4Fig. Long-term survival after open and endovascular repair of ruptured
abdominal aortic aneurysm.[2.5-4.5]) on admission predicted mortality at 1 and 5 years after RAAA
repair. Type I endoleak (HR, 2.2 [1.2-3.8]) also predictedmortality at 1 year.
Conclusions: EVAR does not independently reduce long-term mor-
tality compared with OR. Patient comorbidities and indices of shock on
admission are the primary independent determinants of long-term mortality.
However, the lower early mortality observed in the VQI for patients
selected to undergo EVAR of RAAA compared with patients selected for
OR is sustained over time, supporting the use of EVAR for RAAA in appro-
priate candidates. Better elucidation of the key selection factors, including
aneurysm anatomy, is needed to best select patients for EVAR and OR in
order to reduce long-term mortality.
Author Disclosures: W. P. Robinson: None; A. Schanzer: None; F.
Aiello: None; J. Flahive: None; D. R. Doucet: None; J. P. Simons:
None; E. Arous: None; L. M. Messina: None.Abdominal Aortic Aneurysm Anatomic Severity Grading
Score Predicts Aortic Branch Vessel Complications,
Nonaortic Adverse Events, and Survival
William B. Best, BS, S. Sadie Ahanchi, MD, Kedar S. Lavingia, Chad P.
Ammar, MD, Sebastian Larion, MS, Jean M. Panneton, MD, FRCSC.
Eastern Virginia Medical School, Norfolk, Va
Objectives: Our aim was to examine the predictive value of the
Anatomic Severity Grading (ASG) score on aortic branch vessel complica-
tions, nonaortic adverse events, and survival.
Methods: Using three-dimensional reconstruction of preoperative
computed tomography angiography imaging (TeraRecon; Aquarius iNtui-
tionWorkstation, Foster City, Calif), we retrospectively reviewed endovascu-
lar aneurysm repairs (EVARs) from 2009 to 2012. Two independent patient
groups were created based on ASG score: <14 (low-score group) and $14
(high-score group). Aortic branch vessel complications, nonaortic adverse
events, and survival were collected and analyzed in relation to ASG score.
Results: We analyzed 218 patients. Mean age was 74 years (range, 48-
92), 75% were male and 83% were Caucasian; 114 were in the low-score
group and 104 were in the high-score group. Excluding age, there were no
other differences in demographics between groups. There were 17 patients
with 30-day aortic branch vessel complications: claudication or rest pain
(50%), renal insufﬁciency (39%), and spinal or mesenteric ischemia (11%).
The incidence of 30-day branch vessel complications was signiﬁcantly
different between the low-score group (n¼ 5 [4%]) and the high score group
(n ¼ 12 [11%]; P ¼ .049). There were 23 patients with 30-day nonaortic
adverse events: pulmonary dysfunction (46%), coagulopathy (32%), deep
vein thrombosis (DVT; 14%), myocardial infarction (4%), and cerebrovascu-
lar accident (CVA; 4%). The incidence of 30-day nonaortic adverse events
trended toward statistical signiﬁcance when analyzing the low-score group
(n ¼ 8 [7%]) vs the high-score group (n ¼ 15 [14%]; P ¼ .075). When we
combined 30-day aortic branch vessel complications with 30-day nonaortic
adverse events, we found that the low-score group was statistically different
from the high-score group (n ¼ 10 [9%] vs n ¼ 23 [22%]; P ¼ .006). After
30 days, 40 patients hadmidterm aortic branch complications and 41 patients
had nonaortic adverse events. After Kaplan-Meier analysis, the freedom from
adverse events was statistically different at 1 year (80% vs 71%) and 2 years
(79% vs 65%; P¼ .006). Lastly, Kaplan-Meier analysis revealed a signiﬁcantly
longer survival in the low-score group (93% and 90% at 1 and 4 years) vs the
high-score group (88% and 80% at 1 and 4 years; P ¼ .022).
Conclusions: The abdominal aortic aneurysmASG score can be used not
only to predict operative complexity and reinterventions but also 30-day and
midtermaorticbranchvessel complications, nonaortic adverseevents, and survival.
